論文 |
papers |
-
Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry Chisato Terada,Kaho Oh,Ryutaro Tsubaki,Bun Chan,Nozomi Aibara,Kaname Ohyama,Masa-Aki Shibata,Takehiko Wada,Mariko Harada-Shiba,Asako Yamayoshi,Tsuyoshi Yamamoto Nature Communications 14巻1号 2023年12月02日
-
Exosome-Hijacking Drug Delivery System with Branched Arginine Linker Effectively Deliver Antisense Oligonucleotides into Lung Adenocarcinoma Cells. Shota Oyama,Mao Tomita,Moeka Hata,Yu Mikame,Tsuyoshi Yamamoto,Eishi Ashihara,Asako Yamayoshi Chemical & pharmaceutical bulletin 71巻11号819頁-823頁 2023年11月01日
-
Development and Crosslinking Properties of Psoralen-Conjugated Triplex-Forming Oligonucleotides as Antigene Tools Targeting Genome DNA. Yu Mikame,Honoka Eshima,Haruki Toyama,Juki Nakao,Misaki Matsuo,Tsuyoshi Yamamoto,Yoshiyuki Hari,Jun A Komano,Asako Yamayoshi ChemMedChem e202300348頁- 2023年09月13日
-
Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin-2. Sachiko Horie,Yasuhiro Suzuki,Tsuyoshi Yamamoto,Satoshi Obika,Kohta Mohri,Chizuru Kiyota,Qin Ren,Shota Warashina,Yasuhiro Wada,Yasuyoshi Watanabe,Hidefumi Mukai,Yasufumi Sato Cancer science 2023年07月10日
-
Unique Crosslinking Properties of Psoralen-conjugated Oligonucleotides developed by Novel Psoralen N-Hydroxysuccinimide Esters. Juki Nakao,Yu Mikame,Honoka Eshima,Tsuyoshi Yamamoto,Chikara Dohno,Takehiko Wada,Asako Yamayoshi Chembiochem : a European journal of chemical biology e202200789頁- 2023年03月10日
-
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules Chisato Terada,Seiya Kawamoto,Asako Yamayoshi,Tsuyoshi Yamamoto Pharmaceutics 14巻12号2647頁-2647頁 2022年11月29日
-
Selective Photo-Crosslinking Detection of Methylated Cytosine in DNA Duplex Aided by a Cationic Comb-Type Copolymer Atsuhiro Kojima,Juki Nakao,Naohiko Shimada,Naoki Yoshida,Yota Abe,Yu Mikame,Tsuyoshi Yamamoto,Takehiko Wada,Atsushi Maruyama,Asako Yamayoshi ACS Biomaterials Science & Engineering 2022年03月09日
-
Synthesis and Evaluation of Oligonucleotide-Containing 2’-O-{[(4,5’,8-trimethylpsoralen)-4’-ylmethoxy]ethylaminocarb-onyl}adenosine as Photo-crosslinkable Gene Targeting Tools Yu Mikame,Yui Sakai,Ryo Tahara,Kinuka Doi,Tsuyoshi Yamamoto,Chikara Dohno,Takayuki Shibata,Asako Yamayoshi Chemical and Pharmaceutical Bulletin 70巻10号726頁-730頁 2022年
-
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides Fumito Wada,Tsuyoshi Yamamoto,Tadayuki Kobayashi,Keisuke Tachibana,Kosuke Ramon Ito,Mayumi Hamasaki,Yukina Kayaba,Chisato Terada,Asako Yamayoshi,Satoshi Obika,Mariko Harada-Shiba Molecular Therapy - Nucleic Acids 26巻957頁-969頁 2021年12月
-
Therapeutic application of sequence-specific binding molecules for novel genome editing tools Juki Nakao,Tsuyoshi Yamamoto,Asako Yamayoshi Drug Metabolism and Pharmacokinetics 42巻100427頁-100427頁 2021年10月
-
Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry Chisato Terada,Kaho Oh,Ryutaro Tsubaki,Bun Chan,Nozomi Aibara,Kaname Ohyama,Masa-Aki Shibata,Takehiko Wada,Mariko Harada-Shiba,Asako Yamayoshi,Tsuyoshi Yamamoto Nature Communications 14.1. 2023/12/02
-
Exosome-Hijacking Drug Delivery System with Branched Arginine Linker Effectively Deliver Antisense Oligonucleotides into Lung Adenocarcinoma Cells. Shota Oyama,Mao Tomita,Moeka Hata,Yu Mikame,Tsuyoshi Yamamoto,Eishi Ashihara,Asako Yamayoshi Chemical & pharmaceutical bulletin 71.11.819-823 2023/11/01
-
Development and Crosslinking Properties of Psoralen-Conjugated Triplex-Forming Oligonucleotides as Antigene Tools Targeting Genome DNA. Yu Mikame,Honoka Eshima,Haruki Toyama,Juki Nakao,Misaki Matsuo,Tsuyoshi Yamamoto,Yoshiyuki Hari,Jun A Komano,Asako Yamayoshi ChemMedChem e202300348- 2023/09/13
-
Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin-2. Sachiko Horie,Yasuhiro Suzuki,Tsuyoshi Yamamoto,Satoshi Obika,Kohta Mohri,Chizuru Kiyota,Qin Ren,Shota Warashina,Yasuhiro Wada,Yasuyoshi Watanabe,Hidefumi Mukai,Yasufumi Sato Cancer science 2023/07/10
-
Unique Crosslinking Properties of Psoralen-conjugated Oligonucleotides developed by Novel Psoralen N-Hydroxysuccinimide Esters. Juki Nakao,Yu Mikame,Honoka Eshima,Tsuyoshi Yamamoto,Chikara Dohno,Takehiko Wada,Asako Yamayoshi Chembiochem : a European journal of chemical biology e202200789- 2023/03/10
-
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules Chisato Terada,Seiya Kawamoto,Asako Yamayoshi,Tsuyoshi Yamamoto Pharmaceutics 14.12.2647-2647 2022/11/29
-
Selective Photo-Crosslinking Detection of Methylated Cytosine in DNA Duplex Aided by a Cationic Comb-Type Copolymer Atsuhiro Kojima,Juki Nakao,Naohiko Shimada,Naoki Yoshida,Yota Abe,Yu Mikame,Tsuyoshi Yamamoto,Takehiko Wada,Atsushi Maruyama,Asako Yamayoshi ACS Biomaterials Science & Engineering 2022/03/09
-
Synthesis and Evaluation of Oligonucleotide-Containing 2’-O-{[(4,5’,8-trimethylpsoralen)-4’-ylmethoxy]ethylaminocarb-onyl}adenosine as Photo-crosslinkable Gene Targeting Tools Yu Mikame,Yui Sakai,Ryo Tahara,Kinuka Doi,Tsuyoshi Yamamoto,Chikara Dohno,Takayuki Shibata,Asako Yamayoshi Chemical and Pharmaceutical Bulletin 70.10.726-730 2022
-
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides Fumito Wada,Tsuyoshi Yamamoto,Tadayuki Kobayashi,Keisuke Tachibana,Kosuke Ramon Ito,Mayumi Hamasaki,Yukina Kayaba,Chisato Terada,Asako Yamayoshi,Satoshi Obika,Mariko Harada-Shiba Molecular Therapy - Nucleic Acids 26.957-969 2021/12
-
Therapeutic application of sequence-specific binding molecules for novel genome editing tools Juki Nakao,Tsuyoshi Yamamoto,Asako Yamayoshi Drug Metabolism and Pharmacokinetics 42.100427-100427 2021/10
|